The importance of a 3D T1 sequence

In this post, I explore why NeuroQuant processing uses a 3D T1 sagittal MRI sequence and that using other sequences will generate an unsupported MR sequence error message.

Previously, I reviewed how to ensure accurate NeuroQuant processing results, and my colleague discussed why contrast agents are not used to achieve quality segmentation with NeuroQuant, and examined why good alignment to atlas is necessary for accurate NeuroQuant output.

3D T1 sagittal MRIs are needed to obtain ideal brain morphometry for volume analysis. In order to achieve its high-quality segmentation results, NeuroQuant has been optimized for processing 3D T1 sagittal MRI acquisition sequence in 1.2, 1.5 and 3.0T scanners.

As a quality control feature, NeuroQuant contains a data filtering mechanism that provides verification of study scanning parameters prior to initiating processing. Ensuring proper processing preserves the accuracy of the segmentation results and therefore, the accuracy of the calculated brain volumes. To protect the accuracy of the results, NeuroQuant prevents analysis when sequences other than 3D T1 are sent for processing.

The unsupported sequences provided as examples below will generate an error message.

unsupported_seq.png

Another example that will generate an error message happens when the wrong series (or entire exam) is sent. When an entire exam is sent instead of just the required 3D T1 NeuroQuant scan, there can be a  delay in the return of NeuroQuant results, which will result in multiple error messages being sent back to the PACS.

More information about using and processing NeuroQuant can be found here.

More Resources

04/02/2025

Pediatric Neuroimaging Insights: The NeuroQuant® Age Range Series

Brain volumetrics play a pivotal role in understanding pediatric neurological development. Explore how NeuroQuant® enhances neuroimaging from ages 3 to 100.

03/31/2025

How NeuroAlign CT Subtraction Maps Enhance Detection and Confidence in Neuroradiology

What if head CT assessment could be even faster and more accurate? Subtraction maps allow for improved detection and visualization of subtle interval changes.

03/27/2025

Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India

We are pleased to announce a strategic partnership with Kryptonite Solutions to distribute our innovative portfolio across India.

03/20/2025

Cortechs.ai Announces Strategic Distribution Partnership with Medical Horizons to Expand Presence in Italy, Turkey, and the Middle East

We are pleased to announce a strategic distribution partnership with Medical Horizons, a premier AI-powered medical device distributor based in Florence, Italy.

03/18/2025

Unlocking the Power of AI Imaging in Multiple Sclerosis: How NeuroQuant® MS Enhances Lesion Detection and Monitoring

Unlock the power of AI-driven imaging with NeuroQuant® MS—enhancing lesion detection, monitoring, and personalized care for Multiple Sclerosis.

03/09/2025

Advancing TBI Evaluation with AI-Driven MRI Analysis: A New Era in Brain Health

AI-driven MRI with NeuroQuant® enhances TBI assessment, tracks recovery, and supports better treatment decisions.
Scroll to Top